Earnings Report·May 5, 2026
IDEXX Laboratories (NASDAQ: IDXX) Raises Guidance on Strong Pet Diagnostics Demand
Pet diagnostics leader IDEXX beat Q1 expectations and lifted full-year forecasts, signaling robust demand in veterinary care.
IDEXX Laboratories Inc. (NASDAQ: IDXX) Stock News & Analysis
IDEXX Laboratories Inc. (NASDAQ: IDXX) is a healthcare company, listed on the NASDAQ. Alpha Stocks Insight has published 2 articles on IDXX since May 5, 2026, most recently "IDEXX Laboratories (NASDAQ:IDXX) Q2 2026 EPS of $4.27 Beats by 6.1%, Full-Year Outlook Raised" on Wednesday, August 5, 2026. Coverage to date spans Earnings Report, tracking IDXX's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
IDXX Coverage -- 2 Articles
Earnings Report·Wednesday, August 5, 2026
IDEXX Laboratories (NASDAQ:IDXX) Q2 2026 EPS of $4.27 Beats by 6.1%, Full-Year Outlook Raised
IDXX posted EPS of $4.27 vs. a $4.02 estimate on $1.217B in revenue, and lifted its 2026 EPS guidance midpoint to $14.82 from $14.68.
4 min readRead article
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.